Yiran Qian – Boston Collaborative Drug Surveillance Program (BCDSP)

The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids

By BCDSP November 7, 2020Uncategorized

Journal: Rheumatology (Oxford) Authors: Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick NLM Citation: Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risks of major cardiac events among…

Proton-pump inhibitor use and myocardial infarction: a nested case-control study in the UK Clinical Practice Research Datalink

By BCDSP May 31, 2020Drug Safety Studies, Recent student studies conducted at BCDSP, Safety of other important drugs, Select Publications, Student Studies

Journal: Epidemiology (Cambridge, MA) Authors: Yiran Qian, Susan Jick NLM Citation: Qian Y, Jick S. Proton-pump inhibitor use and myocardial infarction: a nested case-control study in the UK Clinical Practice Research…

The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database

By BCDSP March 25, 2020Drug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications

Journal: Journal of the American Academy of Dermatology Authors: Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick NLM Citation: Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risk…